Kimiaei Parichehr, Khani Zahra, Marefian Azadeh, Gholampour Ghavamabadi Maryam, Salimnejad Maryam
Department of Obstetrics and Gynecology, Mahdiyeh Hospital, Shahid Beheshti University of Medical Sciences, No. 16, Fadaieaneslam Street, Shoush Avenue, Tehran 1185817311, Iran.
ISRN Obstet Gynecol. 2013 May 14;2013:269425. doi: 10.1155/2013/269425. Print 2013.
This retrospective cohort study was designed in a selective group of 185 patients diagnosed with and treated for ectopic pregnancy. Intramuscular administration of a single dose of methotrexate (50 mg/m(2)) was performed to measure predictors of failure or resistance to treatment necessitating surgical intervention. During the time of treatment with a single dose of MTX, 20 patients (10.8%) failed to response, in which 6 of 20 (30%) indicated side effects to MTX and rupture of the ectopic pregnancy. Remaining cases (n = 14) showed resistance to the drug; the level of β -hCG did not fall at least 15% during 7 days after treatment and necessitated laparotomy. In backward-step analysis by multiple logistic regressions of various types of predictor factors, size of gestational sac (coefficient = 1.91, OR = 6.78, 95% confidence interval = 3.18-8.22) and baseline level β -hCG (coefficient = 1.60, OR = 5.0, 95% confidence interval = 4.26-6.72) had significant correlation with leading EP patients failing to response to MTX. This study suggests that further investigation for finding relative contraindications of MTX treatment in EP women should be considered on the gestational sac size because other variables are in the causal pathway of this variable.
这项回顾性队列研究纳入了185例确诊并接受异位妊娠治疗的患者。采用单剂量甲氨蝶呤(50mg/m²)肌肉注射,以测定治疗失败或抵抗从而需要手术干预的预测因素。在单剂量甲氨蝶呤治疗期间,20例患者(10.8%)治疗无反应,其中20例中有6例(30%)出现对甲氨蝶呤的副作用及异位妊娠破裂。其余病例(n = 14)显示对药物有抵抗;治疗后7天内β -hCG水平至少未下降15%,需要进行剖腹手术。在对各种预测因素进行多因素逻辑回归的向后逐步分析中,孕囊大小(系数 = 1.91,OR = 6.78,95%置信区间 = 3.18 - 8.22)和基线β -hCG水平(系数 = 1.60,OR = 5.0,95%置信区间 = 4.26 - 6.72)与主要异位妊娠患者对甲氨蝶呤治疗无反应显著相关。本研究表明,鉴于其他变量处于该变量的因果路径中,应考虑基于孕囊大小对异位妊娠女性甲氨蝶呤治疗的相对禁忌证进行进一步研究。